These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26458642)

  • 41. Aggressive multimodality treatment for primary malignant peritoneal mesothelioma.
    Teoh WC; Haghighi KS; Morris DL
    ANZ J Surg; 2001 Nov; 71(11):683-5. PubMed ID: 11736836
    [No Abstract]   [Full Text] [Related]  

  • 42. Analysis of prognostic factors of patients with malignant peritoneal mesothelioma.
    Yin W; Zheng G; Yang K; Song H; Liang Y
    World J Surg Oncol; 2018 Mar; 16(1):44. PubMed ID: 29506546
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Diffuse malignant peritoneal mesothelioma (DMPM) - a rare diagnosis].
    Habbel VSA; Mahler EA; Feyerabend B; Oldhafer KJ; Lipp MJ
    Z Gastroenterol; 2020 Feb; 58(2):146-151. PubMed ID: 32050285
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Malignant peritoneal mesothelioma.
    Bani-Hani KE; Gharaibeh KA
    J Surg Oncol; 2005 Jul; 91(1):17-25. PubMed ID: 15999348
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic significance of histomorphologic parameters in diffuse malignant peritoneal mesothelioma.
    Cerruto CA; Brun EA; Chang D; Sugarbaker PH
    Arch Pathol Lab Med; 2006 Nov; 130(11):1654-61. PubMed ID: 17076527
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of a combination of pemetrexed and multiple redo-surgery in an 11-year-old girl with a recurrent multifocal abdominal mesothelioma.
    Milano E; Pourroy B; Rome A; Delarue A; Coze C; Gorincour G; Bouvier C; Braguer D; André N
    Anticancer Drugs; 2006 Nov; 17(10):1231-4. PubMed ID: 17075325
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival.
    Sugarbaker PH; Chang D
    Eur J Surg Oncol; 2017 Jul; 43(7):1228-1235. PubMed ID: 28189456
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesothelioma.
    Yan TD; Yoo D; Sugarbaker PH
    Eur J Surg Oncol; 2006 Nov; 32(9):948-53. PubMed ID: 16806796
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conversion to Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma After Bidirectional Chemotherapy.
    Le Roy F; Gelli M; Hollebecque A; Honoré C; Boige V; Dartigues P; Benhaim L; Malka D; Ducreux M; Elias D; Goéré D
    Ann Surg Oncol; 2017 Nov; 24(12):3640-3646. PubMed ID: 28849389
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pleurectomy/decortication and hyperthermic intrapleural chemotherapy for malignant pleural mesothelioma: initial experience.
    Migliore M; Calvo D; Criscione A; Palmucci S; Fuccio Sanzà G; Caltabiano R; Spatola C; Privitera G; Aiello MM; Parra HS; Ciancio N; Di Maria G
    Future Oncol; 2015; 11(24 Suppl):19-22. PubMed ID: 26638918
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diffuse malignant peritoneal mesothelioma.
    Shih CA; Ho SP; Tsay FW; Lai KH; Hsu PI
    Kaohsiung J Med Sci; 2013 Nov; 29(11):642-5. PubMed ID: 24183360
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma and predictors of survival.
    Gilani SNS; Mehta A; Garcia-Fadrique A; Rowaiye B; Jenei V; Dayal S; Chandrakumaran K; Carr N; Mohamed F; Cecil T; Moran B
    Int J Hyperthermia; 2018 Aug; 34(5):578-584. PubMed ID: 29431036
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Cabras AD; Dileo P; Laterza B; Deraco M
    Ann Surg Oncol; 2009 Feb; 16(2):463-72. PubMed ID: 19082859
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined MEK and PI3K/p110β Inhibition as a Novel Targeted Therapy for Malignant Mesothelioma Displaying Sarcomatoid Features.
    Marqués M; Tranchant R; Risa-Ebrí B; Suárez-Solís ML; Fernández LC; Carrillo-de-Santa-Pau E; Del Pozo N; Martínez de Villarreal J; Meiller C; Allory Y; Blum Y; Pirker C; Hegedus B; Barry ST; Carnero A; Berger W; Jean D; Real FX
    Cancer Res; 2020 Feb; 80(4):843-856. PubMed ID: 31911549
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diffuse malignant peritoneal mesothelioma in a 13-year-old girl. Report of a case and review of the literature.
    Talerman A; Montero JR; Chilcote RR; Okagaki T
    Am J Surg Pathol; 1985 Jan; 9(1):73-80. PubMed ID: 3970301
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Malignant mesothelioma in the peritoneal cavity - a case report].
    Rupert K; Třeška V
    Rozhl Chir; 2015 Apr; 94(4):166-9. PubMed ID: 25866103
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A case of malignant peritoneal mesothelioma with the epithelioid histological type, successfully treated with pemetrexed plus cisplatin].
    Kobayashi M; Moriwaki T; Ochi D; Saito R; Kobayashi K; Sugaya A; Akutsu D; Hamano Y; Imanishi M; Yamamoto Y; Yamada T; Nakano N; Sugano M; Hara K; Hyodo I
    Gan To Kagaku Ryoho; 2014 Mar; 41(3):361-4. PubMed ID: 24743284
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiological predictors of complete cytoreduction in 59 patients with peritoneal mesothelioma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a UK referral centre.
    Chandramohan A; Thrower A; Shah N; Mohamed F
    Br J Radiol; 2017 Nov; 90(1079):20170361. PubMed ID: 28830230
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Laparoscopy and primary diffuse malignant peritoneal mesothelioma: a diagnostic challenge.
    Van de Walle P; Blomme Y; Van Outryve L
    Acta Chir Belg; 2004 Feb; 104(1):114-7. PubMed ID: 15053478
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study.
    Brigand C; Monneuse O; Mohamed F; Sayag-Beaujard AC; Isaac S; Gilly FN; Glehen O
    Ann Surg Oncol; 2006 Mar; 13(3):405-12. PubMed ID: 16485159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.